Scientific Agenda
Friday, March 16, 2012
Master Class: Management of IBD in Children, Teens, and Young Adults
Co-Chairs: Joel R. Rosh, MD, and Robbyn E. Sockolow, MD
1:00 pm
Welcome and pre-activity audience knowledge/competence assessment via ARS
1:15 pm
Risk stratification of pediatric IBD: What disease does your patient really have?
Wallace V. Crandall, MD
1:45 pm
Optimizing the safety and efficacy of biologics in pediatric IBD
Robert N. Baldassano, MD
2:15 pm
Faculty panel: What roles do immunomodulators play in managing pediatric IBD?
Moderator: Joel R. Rosh, MD
2:45 pm
Faculty panel: Optimal therapy during post-SONIC era
Moderator: Robbyn E. Sockolow, MD
3:15 pm
Break
3:35 pm
Faculty panel: Mucosal healing or clinical criteria: How should remission be defined in pediatric IBD?
Moderator: Joel R. Rosh, MD
4:05 pm
Vaccination/health maintenance talk
Robbyn E. Sockolow, MD
4:30 pm
Acute pediatric ulcerative colitis: Lessons from the OSCI trial
Anne Griffiths, MD
4:55 pm
Challenging cases in IBD
Moderators: Joel R. Rosh, MD and Robbyn E. Sockolow, MD
5:35 pm
Adjourn
Saturday, March 17, 2012
Practical Insights in the Management of Adult IBD
Co-chairs: Marla C. Dubinsky, MD, and Asher A. Kornbluth, MD
7:00 am
Breakfast
8:00 am
Welcome and pre-activity audience knowledge/competence assessment via ARS
8:15 am
Vaccinations and other health maintenance issues for the patient on immune suppressive therapies
Gil Y. Melmed, MD, MS
8:35 am
Management of pregnant women with IBD
Marla C. Dubinsky, MD
8:55 am
Q and A
Moderator: Marla C. Dubinsky, MD
9:05 am
Debate: Combination therapy should be continued indefinitely in IBD
Moderator: Edward V. Loftus, Jr, MD, FACG
Pro: Yes, you can never stop combination therapy
Miguel D. Regueiro, MD
Con: No, it is feasible to stop and use monotherapy
Gil Y. Melmed, MD, MS
Diagnostic imaging
9:35 am
Small bowel imaging – Choosing the best radiologic modalities
Edward V. Loftus, Jr, MD, FACG
9:50 am
Non radiologic imaging of the small bowel: Capsule endoscopy and double balloon enteroscopy
Asher A. Kornbluth, MD
10:05 am
Q and A
Moderator: Thomas A. Ullman, MD, FACG
10:15 am
Coffee Break
Optimization of biologic treatment
10:30 am
In biologic naive patients
Bruce E. Sands, MD, MS, FACG
10:45 am
In patients losing response to an anti-TNF agent
Scott Plevy, MD
11:00 am
Q and A
Moderator: Thomas A. Ullman, MD, FACG
11:15 am
Debate: Low Grade Dysplasia is an indication for colectomy
Moderator: Asher A. Kornbluth, MD
Point: Yes, a colectomy is the right choice
Thomas A. Ullman, MD, FACG
Counterpoint: No, patients do not need a colectomy
Fernando S. Velayos, MD, MPH
11:45 am
Debate: Post-op therapy is necessary for all patients
Moderator: Fernando S. Velayos, MD, MPH
Point: Yes
Miguel D. Regueiro, MD
Counterpoint: No
Scott Plevy, MD
12:15 pm
Q and A
Moderator: Fernando S. Velayos, MD, MPH
12:30 pm
Meet the Experts – Lunch served
1:30 pm
Balancing and explaining risks of therapy in patients’ treatment options
Bruce E. Sands, MD, MS, FACG
1:50 pm
Therapeutic monitoring and maximizing therapeutic response to immunomodulators and biologics
Marla C. Dubinsky, MD
2:10 pm
State of the art: An update on the management of severe ulcerative colitis
Asher A. Kornbluth, MD
2:30 pm
Panel discussion: Frequently asked questions
All faculty
3:00 pm
Break
3:15 pm
Gastroenterology Board review – Clinical cases and questions for the practicing gastroenterologist and GI Fellow preparing for Board certification or recertification
Moderators: Marla C. Dubinsky, MD and Asher A. Kornbluth, MD
Faculty panel: Scott Plevy, MD, Gil Y. Melmed, MD, MS, Thomas A. Ullman, MD, FACG, Bruce E. Sands, MD, MS, FACG, Fernando S. Velayos, MD, MPH, Edward V. Loftus, Jr, MD, FACG, Miguel D. Regueiro, MD
4:30 pm
Conclusion and wrap-up summary
4:45 pm
Adjourn